Skip to main content
TipRanks
Go Ultimate75% OFF

Michael H. Goldstein Insider Profile

4 Followers

Michael H. Goldstein, President, Ophthalmology & CMO at Ocular Therapeutix, holds 313.33K shares in Ocular Therapeutix (Ticker: OCUL), holds ― shares in Applied Genetic Technologies (Ticker: AGTC).

Michael H. Goldstein's Trading History

OCUL
Ocular Therapeutix
Feb 07, 2022President, Ophthalmology & CMOUninformative Buy―$1.88M
AGTC
Applied Genetic Technologies
――――

You May Also Like

Michael H. Goldstein insider profile FAQ

What stocks does Michael H. Goldstein hold?
Michael H. Goldstein holds: OCUL, AGTC stocks.
What is Michael H. Goldstein's role in Ocular Therapeutix?
Michael H. Goldstein's role in Ocular Therapeutix is President, Ophthalmology & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.